IV Thrombolysis & Mechanical Thrombectomy: Opponents or Team Players for Acute Ischemic Stroke?, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the history of recanalization strategies and current treatment guidelines as well as recent research examining the utility of pharmacological interventions. Attendees will learn about the potential for complementary approaches with mechanical and pharmacological recanalization and strategies for optimizing study design and enhancing patient recruitment.

Xtalks Life Science Webinars

From the standpoint of clinical trial operations, the speakers will also discuss thrombolytic treatment options as they relate to the infrastructure of stroke centers and their capacity

Every minute matters after acute ischemic stroke (AIS) onset in the path to recovery. Early treatment is essential for both IV-Thrombolysis (IVT) and mechanical thrombectomy (MT). Recent research has explored extending the standard treatment window by using advanced imaging selection when administering IVT or MT. Many questions remain about whether IV thrombolysis or interventional mechanical thrombectomy is better suited for the treatment of AIS.

Join three thought leaders in the fields as they provide an overview of pharmacological and mechanical avenues to recanalization. They will discuss recently published trials, major advances in MT and IVT over the last five years, combination of IVT and MT, especially in patients transferred from other hospitals, and the potential utility of thrombectomy and treatment approach for distal occlusions.

From the standpoint of clinical trial operations, the speakers will also discuss thrombolytic treatment options as they relate to the infrastructure of stroke centers and their capacity, given that even many developed countries have been affected by a lack of critical care beds with the COVID-19 pandemic, and similarly may not be prepared to offer novel stroke treatments to all patients affected. Patient referral and recruitment is another topic of interest as researchers consider the pros and cons of broadening study eligibility by widening the time window for thrombolysis, which may make a difference for people in underserved regions of the world.

Join Dileep R. Yavagal, MD, FAHA, FAAN, FSVIN, Clinical Professor of Neurology and Neurosurgery at the University of Miami of Medicine, Werner Hacke, MD, PhD, DSc, FAHA, FESC, Senior Professor of Medicine at the Ruprecht- Karls University in Heidelberg and Francisco J. Martinez-Torres, MD, PhD, Senior Medical Director, Neuroscience, Global Clinical Development in a live webinar on Thursday, September 10, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit IV Thrombolysis & Mechanical Thrombectomy: Opponents or Team Players for Acute Ischemic Stroke?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website